Search Results 111-120 of 21354 for anti-TNF drugs

  1. centers-of-excellence

    Adalimumab-Adbm (Subcutaneous Route) Before Using - Mayo Clinic. Skip to content Care at Mayo Clinic Patient-Centered Care About Mayo ...

  2. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...

  3. Inflammatory bowel disease biobank research update - Mayo Clinic

    ... anti-tumor necrosis factor (TNF) therapy. They examined how a patient's genetic risk burden or profile affects the disease course and individual responses ...

  4. NSAIDs: Do they increase my risk of heart attack and stroke? - Mayo Clinic

    Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) can increase the risk of heart attack and stroke. These medicines most often treat pain, swelling and ...

  5. Clinical Trials - Mayo Clinic Research

    ... Anti-TNF Therapy (Step-Up HS) A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With ...

  6. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

    ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

  7. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

  8. A Study to Evaluate the Effectiveness and Safety of Triple Combination Therapy in High Risk Crohn's Disease (CD) - Mayo Clinic

    ... anti-integrin (vedolizumab intravenous [IV]), a tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral ...

  9. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

  10. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Additionally, some of these drugs are weight-based, while others are fixed doses. ... Examining clinical and genetic factors that impact response to anti-TNF ...